These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15147951)

  • 1. Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate.
    Kuo CJ; Chi YH; Hsu JT; Liang PH
    Biochem Biophys Res Commun; 2004 Jun; 318(4):862-7. PubMed ID: 15147951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A continuous fluorescence-based assay of human cytomegalovirus protease using a peptide substrate.
    Holskin BP; Bukhtiyarova M; Dunn BM; Baur P; de Chastonay J; Pennington MW
    Anal Biochem; 1995 May; 227(1):148-55. PubMed ID: 7668375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer.
    Matayoshi ED; Wang GT; Krafft GA; Erickson J
    Science; 1990 Feb; 247(4945):954-8. PubMed ID: 2106161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay.
    Kao RY; To AP; Ng LW; Tsui WH; Lee TS; Tsoi HW; Yuen KY
    FEBS Lett; 2004 Oct; 576(3):325-30. PubMed ID: 15498556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique.
    Chen S; Chen LL; Luo HB; Sun T; Chen J; Ye F; Cai JH; Shen JK; Shen X; Jiang HL
    Acta Pharmacol Sin; 2005 Jan; 26(1):99-106. PubMed ID: 15659121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-chain recombinant human cytomegalovirus protease. Activity against its natural protein substrate and fluorogenic peptide substrates.
    Pinko C; Margosiak SA; Vanderpool D; Gutowski JC; Condon B; Kan CC
    J Biol Chem; 1995 Oct; 270(40):23634-40. PubMed ID: 7559530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease: identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata.
    Hamill P; Hudson D; Kao RY; Chow P; Raj M; Xu H; Richer MJ; Jean F
    Biol Chem; 2006 Aug; 387(8):1063-74. PubMed ID: 16895476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
    Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
    J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A continuous fluorimetric assay for tail-specific protease.
    Beebe KD; Pei D
    Anal Biochem; 1998 Oct; 263(1):51-6. PubMed ID: 9750142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer-based assays.
    Kuang WF; Chow LP; Wu MH; Hwang LH
    Biochem Biophys Res Commun; 2005 Jun; 331(4):1554-9. PubMed ID: 15883050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.
    Tomar S; Johnston ML; St John SE; Osswald HL; Nyalapatla PR; Paul LN; Ghosh AK; Denison MR; Mesecar AD
    J Biol Chem; 2015 Aug; 290(32):19403-22. PubMed ID: 26055715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease.
    Hsu WC; Chang HC; Chou CY; Tsai PJ; Lin PI; Chang GG
    J Biol Chem; 2005 Jun; 280(24):22741-8. PubMed ID: 15831489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations.
    Chen S; Chen L; Tan J; Chen J; Du L; Sun T; Shen J; Chen K; Jiang H; Shen X
    J Biol Chem; 2005 Jan; 280(1):164-73. PubMed ID: 15507456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic activation of recombinant pro-memapsin 2 (pro-beta-secretase) studied with new fluorogenic substrates.
    Ermolieff J; Loy JA; Koelsch G; Tang J
    Biochemistry; 2000 Oct; 39(40):12450-6. PubMed ID: 11015226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease.
    Shie JJ; Fang JM; Kuo CJ; Kuo TH; Liang PH; Huang HJ; Yang WB; Lin CH; Chen JL; Wu YT; Wong CH
    J Med Chem; 2005 Jun; 48(13):4469-73. PubMed ID: 15974598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors.
    Chen LR; Wang YC; Lin YW; Chou SY; Chen SF; Liu LT; Wu YT; Kuo CJ; Chen TS; Juang SH
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3058-62. PubMed ID: 15896959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.
    Zhu L; George S; Schmidt MF; Al-Gharabli SI; Rademann J; Hilgenfeld R
    Antiviral Res; 2011 Nov; 92(2):204-12. PubMed ID: 21854807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A general method for the preparation of internally quenched fluorogenic protease substrates using solid-phase peptide synthesis.
    Maggiora LL; Smith CW; Zhang ZY
    J Med Chem; 1992 Oct; 35(21):3727-30. PubMed ID: 1433187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease.
    Chou CY; Chang HC; Hsu WC; Lin TZ; Lin CH; Chang GG
    Biochemistry; 2004 Nov; 43(47):14958-70. PubMed ID: 15554703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery.
    Grum-Tokars V; Ratia K; Begaye A; Baker SC; Mesecar AD
    Virus Res; 2008 Apr; 133(1):63-73. PubMed ID: 17397958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.